280 related articles for article (PubMed ID: 12062610)
1. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Intensified Chemoradiation with Intensity-Modulated Radiotherapy and Simultaneous Integrated Boost Combined with Capecitabine in Locally Advanced Rectal Cancer: Long-Term Outcomes of a Real-Life Multicenter Study.
Lupattelli M; Palazzari E; Polesel J; Chiloiro G; Angelicone I; Panni V; Caravatta L; Di Biase S; Macchia G; Niespolo RM; Franco P; Epifani V; Meldolesi E; de Giacomo F; Lucarelli M; Montesi G; Mantello G; Innocente R; Osti MF; Gambacorta MA; Aristei C; De Paoli A
Cancers (Basel); 2023 Dec; 15(23):. PubMed ID: 38067405
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Outcomes in Patients With Locally Advanced Rectal Cancer Undergoing Preoperative Short-
Kim JS; Chung MJ; Lee DY; Lee SH; Jeong SK; Yoo BE; Chung CS; Chung WK
In Vivo; 2023; 37(6):2768-2775. PubMed ID: 37905618
[TBL] [Abstract][Full Text] [Related]
4. Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
Tan BR; Thomas F; Myerson RJ; Zehnbauer B; Trinkaus K; Malyapa RS; Mutch MG; Abbey EE; Alyasiry A; Fleshman JW; McLeod HL
J Clin Oncol; 2011 Mar; 29(7):875-83. PubMed ID: 21205745
[TBL] [Abstract][Full Text] [Related]
5. A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer.
Willett CG; Duda DG; Ancukiewicz M; Shah M; Czito BG; Bentley R; Poleski M; Fujita H; Lauwers GY; Carroll M; Tyler D; Mantyh C; Shellito P; Chung DC; Clark JW; Jain RK
Oncologist; 2010; 15(8):845-51. PubMed ID: 20667969
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer.
Imano N; Murakami Y; Kubo K; Kawahara D; Takeuchi Y; Nishibuchi I; Kimura T; Kochi M; Takakura Y; Shimizu W; Egi H; Uegami S; Ohge H; Takahashi S; Ohdan H; Nagata Y
J Radiat Res; 2021 Mar; 62(2):300-308. PubMed ID: 33341902
[TBL] [Abstract][Full Text] [Related]
7. Downstaging after preoperative chemoradiation for locally advanced rectal cancer is associated with better survival than pathologic stage 0-1 disease treated with upfront surgery.
Kasheri E; Artinyan A; Oka K; Zhu R; Seiser N; Shirinian M; Barnajian M; Cohen J; Ellenhorn J; Nasseri Y
Int J Colorectal Dis; 2024 Jan; 39(1):16. PubMed ID: 38189849
[TBL] [Abstract][Full Text] [Related]
8. Impact of the new AJCC staging system and adjuvant treatment in rectal cancer.
Lee SA; Kwon HC; Park MA; Jung CK; Kim SH; Park KJ; Choi HJ; Lee HS; Roh MS; Kim JS; Kim HJ
Cancer Res Treat; 2004 Apr; 36(2):121-7. PubMed ID: 20396551
[TBL] [Abstract][Full Text] [Related]
9. Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors.
Yoon HI; Koom WS; Kim TH; Ahn JB; Jung M; Kim TI; Kim H; Shin SJ; Kim NK
PLoS One; 2016; 11(8):e0161475. PubMed ID: 27536871
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer-A Pilot Study.
Ong WL; Lunca S; Morarasu S; Musina AM; Puscasu A; Iacob S; Iftincai I; Marinca A; Ivanov I; Roata CE; Velenciuc N; Dimofte G
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893461
[No Abstract] [Full Text] [Related]
11. Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.
Ferrigno R; Novaes PE; Silva ML; Nishimoto IN; Nakagawa WT; Rossi BM; Ferreira Fde O; Lopes A
Radiat Oncol; 2006 Mar; 1():5. PubMed ID: 16722598
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
Azria D; Bibeau F; Barbier N; Zouhair A; Lemanski C; Rouanet P; Ychou M; Senesse P; Ozsahin M; Pèlegrin A; Dubois JB; Thèzenas S
BMC Cancer; 2005 Jun; 5():62. PubMed ID: 15967033
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival and recurrence outcomes following surgery for distal rectal cancer.
Silberfein EJ; Kattepogu KM; Hu CY; Skibber JM; Rodriguez-Bigas MA; Feig B; Das P; Krishnan S; Crane C; Kopetz S; Eng C; Chang GJ
Ann Surg Oncol; 2010 Nov; 17(11):2863-9. PubMed ID: 20552409
[TBL] [Abstract][Full Text] [Related]
14. Combined modality chemoradiation in elderly oesophageal cancer patients.
Anderson SE; Minsky BD; Bains M; Hummer A; Kelsen D; Ilson DH
Br J Cancer; 2007 Jun; 96(12):1823-7. PubMed ID: 17533399
[TBL] [Abstract][Full Text] [Related]
15. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer.
Taku N; Yi-Qian YN; Chang GJ; Ludmir EB; Raghav KPS; Rodriguez-Bigas MA; Holliday EB; Smith GL; Minsky BD; Overman MJ; Messick C; Boyce-Fappiano D; Koong AC; Skibber JM; Koay EJ; Dasari A; Taniguchi CM; Bednarski BK; Morris VK; Kopetz S; Das P
Clin Colorectal Cancer; 2022 Mar; 21(1):e28-e37. PubMed ID: 34794903
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemoradiation in pancreatic cancer: impact of radiotherapy dose on survival.
Morganti AG; Cellini F; Buwenge M; Arcelli A; Alfieri S; Calvo FA; Casadei R; Cilla S; Deodato F; Di Gioia G; Di Marco M; Fuccio L; Bertini F; Guido A; Herman JM; Macchia G; Maidment BW; Miller RC; Minni F; Passoni P; Valentini C; Re A; Regine WF; Reni M; Falconi M; Valentini V; Mattiucci GC
BMC Cancer; 2019 Jun; 19(1):569. PubMed ID: 31185957
[TBL] [Abstract][Full Text] [Related]
17. Impact of Staging Concordance and Downstaging After Neoadjuvant Therapy on Survival Following Resection of Intrahepatic Cholangiocarcinoma: A Bayesian Analysis.
Alaimo L; Moazzam Z; Lima HA; Endo Y; Woldesenbet S; Ejaz A; Cloyd J; Guglielmi A; Ruzzenente A; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4799-4808. PubMed ID: 37029867
[TBL] [Abstract][Full Text] [Related]
18. Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience.
Husseini ZE; Haibe Y; Bouferraa Y; Kreidieh M; Darazi MA; Mukherji D; Temraz S; Charafeddine M; Shamseddine A
Mol Clin Oncol; 2021 Oct; 15(4):220. PubMed ID: 34476104
[TBL] [Abstract][Full Text] [Related]
19. Is There a Role for Adjuvant Chemotherapy in Pathologic Node-Negative Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation Therapy?
Keilson JM; Gamboa AC; Turgeon MK; Maguire L; Hrebinko K; Holder-Murray J; Wiseman JT; Ejaz A; Hawkins AT; Otegbeye E; Silviera M; Maithel SK; Balch GC
Ann Surg Oncol; 2023 Jan; 30(1):224-232. PubMed ID: 36269446
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of preoperative chemoradiotherapy and upfront surgery in the treatment of upper-half rectal cancer: oncological benefits, surgical outcomes, and cost implications.
Wang Y; Wang X; Chen J; Huang S; Huang Y
Updates Surg; 2024 Jan; ():. PubMed ID: 38240957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
